Skip to main content
Log in

Cytotoxicity of taxol in vitro against human and rat malignant brain tumors

  • Short Communication
  • Cytotoxicity, Taxol, Rat Malignant Brain Tumors
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Taxol is a novel antitumor alkaloid that has shown clinical activity against several tumors, including ovarian and breast carcinoma and melanoma. To evaluate taxol's potential as a therapy for malignant brain tumors, we measured the sensitivity of four human (U87, U373, H80, and D324) and two rat (9L, F98) brain-tumor cell lines to taxol. The cells were exposed to taxol in vitro using a clonogenic assay. Log cell kill (LD90) occurred at concentrations of 42 (9L), 25 (F98), 19 (H80), 7.2 (U373), 9.1 (U87), and 3.9 nM (D324) when cells were continuously exposed to taxol for 6–8 days. The human cell lines were uniformly more sensitive to taxol than were the rat lines. The duration of exposure had a significant effect on taxol's cytotoxicity. When cells were exposed to taxol for 1 h the LD90 increased to 890 nM for the 9L rat line and 280 nM for the human U373 line. On the basis of these results, we conclude that taxol has significant potency in vitro against malignant brain tumors and that the activity occurs at concentrations of taxol that have previously been shown to be effective for several tumors against which the drug is currently being evaluated clinically.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Beckman G, Beckman L, Ponten J (1971) G-6-PD and PGM phenotypes of 16 continuous human tumor cell lines. Evidence against cross-contamination and contamination by HeLa cells. Hum Hered 21:238–241

    Google Scholar 

  2. Brem H, Mahaley MS, Vick NA, Black K, Schold SC, Burger PC, Friedman AH, Ciric IS, Eller TW, Cozzens JW, Kenealy JN (1991) Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg 74:441–446

    Google Scholar 

  3. Bullard DE, Schold SC, Bigner SH, Bigner DD (1981) Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines. J Neuropathol Exp Neurol 40:410–427

    Google Scholar 

  4. Grossman S, Reinhard C, Colvin OM, Chasin M, Brundrett R, Tamargo RJ, Brem H (1992) The intracerebral distribution of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) delivery by surgically implanted biodegradable polymers. J Neurosurg 76:640–647

    Google Scholar 

  5. Hanauske AR, Degen D, Hilsenbeck SG, Bissery MC, Hoff DDV (1992) Effects of taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells. Anticancer Drugs 3: 121–124

    Google Scholar 

  6. Horwitz SB, Lothstein L, Manfredi J, Mellado W, Parness J, Roy SN, Schiff PB, Sorbara L, Zeheb R (1986) Taxol: mechanisms of action and resistance. Ann NY Acad Sci 466:733–744

    Google Scholar 

  7. Jacobsen PF, Jenkyn DF, Papadimitriou JM (1985) Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice. J Neuropathol Exp Neurol 44:472–485

    Google Scholar 

  8. Ringel I, Horwitz SB (1987) Taxol is converted to 7-epitaxol, a biologically active isomer, in cell culture medium. J Pharmacol Exp Ther 242:692–698

    Google Scholar 

  9. Riondel J, Jacrot M, Fessi M, Puisieux F (1992) Effects of free and liposome-encapsulated taxol on two brain tumors xenografted into nude mice. In Vivo 6:23–27

    Google Scholar 

  10. Rosenblum ML, Vasquly DA, Hoshino T, Wilson CB (1978) Development of a clonogenic cell assay for human brain tumors. Cancer 41:2305–2314

    Google Scholar 

  11. Roth B, Yeap B, Wilding G, Kasimis B (1992) Taxol (NSC 125973) in advanced, hormone-refractory prostate cancer: an ECOG phase II trial. Proc Annu Meet Am Soc Clin Oncol 11: A598

    Google Scholar 

  12. Rowinsky EK, Cazenave LA, Donehower RC (1990) Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst 82:1247–1259

    Google Scholar 

  13. Rowinsky EK, Donehower RC, Jones RJ, Tucker RW (1988) Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol. Cancer Res 4093–4100

  14. Roytta M, Laine KM, Harkonen P (1987) Morphological studies on the effect of taxol on cultured human prostatic cancer cells. Prostate 11:95–106

    Google Scholar 

  15. Salcman M, Ebert PS (1991) In vitro response of human glioblastoma and canine glioma cells to hyperthermia, radiation, and chemotherapy. Neurosurgery 29:526–531

    Google Scholar 

  16. Smigel K (1993) Taxol, Tamoxifen, and Tsongas: top cancer-related stories of 1992. J Natl Cancer Inst 85:14–16

    Google Scholar 

  17. Tamargo RJ, Brem H (1992) Drug delivery to the central nervous system: a review. Neurosurg Q 2:259–279

    Google Scholar 

  18. Tishler RB, Geard CR, Hall EJ, Schiff PB (1992) Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 52:3495–3497

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cahan, M.A., Walter, K.A., Colvin, O.M. et al. Cytotoxicity of taxol in vitro against human and rat malignant brain tumors. Cancer Chemother. Pharmacol. 33, 441–444 (1994). https://doi.org/10.1007/BF00686276

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00686276

Keywords

Navigation